David M. Marks, MD | Psychiatrist.com

Brief Report

Durability of Benefit From Repeated Intravenous Lidocaine Infusions in Fibromyalgia Patients: A Case Series and Literature Review

September 17, 2015

The authors of this Brief Report tell you about the effective use of serial intravenous lidocaine infusions for the chronic management of 3 patients with fibromyalgia. They describe the...

David M. Marks, Amy Newhouse

Article

A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease

August 15, 2014

Here, review results from a 10-week study that compared the pain-relieving effects of milnacipran, an SNRI, to that of placebo in patients with lumbosacral disc disease. Nerve pain in...

David M. Marks, Chi-Un Pae, Ashwin A. Patkar

Article

Effects of Milnacipran on Neurocognition, Pain, and Fatigue in Fibromyalgia: A 13-Week, Randomized, Placebo-Controlled, Crossover Trial

December 26, 2013

Is milnacipran a safe and effective treatment for improving cognitive function in fibromyalgia? See these study results to find out.

Jeong Lan Kim, Shilpa Rele, David M. Marks, et al

Article

Open-Label Milnacipran for Patients With Persistent Knee Pain 1 Year or Longer After Total Knee Arthroplasty: A Pilot Study

July 11, 2013

Researchers from Duke University conducted a small study of the drug milnacipran in patients who continued to experience knee pain for a year or more despite having an otherwise...

David M. Marks, Michael P. Bolognesi

Original Research

History of Depressive and Anxiety Disorders and Paroxetine Response in Patients With Irritable Bowel Syndrome: Post Hoc Analysis From a Placebo-Controlled Study

October 15, 2008

David M. Marks, Changsu Han, Stan Krulewicz, et al

Original Research

An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features

June 16, 2008

Chi-Un Pae, Prakash S. Masand, Kathleen Peindl, et al